Antidepressants, QTc Changes and Early Heart Risk

Can antidepressants affect the heart's QTc interval?

The QT interval represents the time the heart's ventricles take to electrically activate and recover between beats. Because this interval changes with heart rate, clinicians use a corrected value called QTc. Excessive QTc prolongation can increase susceptibility to torsades de pointes, a potentially dangerous ventricular rhythm, but a modest change does not automatically mean that an arrhythmia will occur.

Cardiac effects differ across antidepressants and may become more relevant with higher doses, interacting medicines, low potassium or magnesium, congenital long-QT syndrome, kidney or liver impairment, and existing cardiovascular disease. The FDA has issued specific QT-related dosing and monitoring guidance for citalopram, illustrating why safety decisions should be made for individual medicines rather than the antidepressant class as a whole.

What does the new antidepressant heart-safety analysis examine?

The BMJ investigation uses individual participant data and network meta-regression from double-blind randomized trials involving adults treated for major depressive disorder. This approach can compare multiple treatments while exploring whether participant characteristics or changes in QTc are associated with early major adverse cardiovascular events.

Such analyses can strengthen comparative safety evaluation, but they do not turn QTc into a complete measure of cardiovascular harm. Serious events are uncommon in many antidepressant trials, follow-up may be relatively short, and trial populations may exclude medically complex patients. QTc is therefore best interpreted alongside symptoms, medical history, dose, concurrent drugs and other clinical findings.

Who may need an ECG before or during antidepressant treatment?

Routine electrocardiograms are not required for every person starting an antidepressant. Clinicians may consider an ECG when a patient has known heart disease, a previous prolonged QTc, unexplained fainting, a family history of sudden cardiac death, significant electrolyte abnormalities, or simultaneous use of several QT-prolonging medicines.

Patients should not stop antidepressants abruptly because of concern about QTc findings. Sudden discontinuation can cause withdrawal symptoms and a return of depression. Palpitations, fainting, seizures, chest pain or a sustained rapid heartbeat warrant prompt medical assessment, while medication changes should be planned with the prescribing clinician.